Cultured peripheral lymphocytes: one biologic indicator of potential drug hazard.
D000293:Adolescent; D000965:Antimony / Q000633:toxicity*; D000966:Antimony Potassium Tartrate / Q000627:therapeutic use / Q000633:toxicity*; D002648:Child; D002675:Child, Preschool; D002877:Chromosomes, Human / Q000187:drug effects*; D064420:Drug-Related Side Effects and Adverse Reactions; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use / Q000633:toxicity*; D008214:Lymphocytes / Q000187:drug effects*; D008297:Male; D008938:Mitosis / Q000187:drug effects*; D009560:Niridazole / Q000627:therapeutic use / Q000633:toxicity*; D014395:Peritonitis, Tuberculous / Q000188:drug therapy; D010672:Phenytoin / Q000627:therapeutic use / Q000633:toxicity*; D012552:Schistosomiasis / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D010672:Phenytoin; D000965:Antimony; D000966:Antimony Potassium Tartrate; D009560:Niridazole; D007538:Isoniazid